AGP FRANKLIN, LLC: CRS position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of AGP FRANKLIN, LLC on CRS, newest first. How the timeline and the estimate are built.
AGP FRANKLIN, LLC held 4,963 CRS shares at 2026-06-30 per its 13F-HR filed 2026-07-30.
the latest 13F is the newest step
- period ended2026-06-3013F 4,963 sharesChange vs previous 13F -151 shares
1.33% of the 13F portfolio, value $3,061,333.
13F-HR 0001951757-26-001079 filed by AGP FRANKLIN, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 5,114 sharesChange vs previous 13F -7,611 shares
1.01% of the 13F portfolio, value $2,015,611.
13F-HR 0001951757-26-000634 filed by AGP FRANKLIN, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 12,725 sharesChange vs previous 13F -144 shares
1.88% of the 13F portfolio, value $4,006,240.
13F-HR 0001951757-26-000320 filed by AGP FRANKLIN, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 12,869 sharesChange vs previous 13F +18 shares
1.54% of the 13F portfolio, value $3,159,907.
13F-HR 0001951757-25-001259 filed by AGP FRANKLIN, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 12,851 sharesChange vs previous 13F -103 shares
1.88% of the 13F portfolio, value $3,551,646.
13F-HR 0001951757-25-001070 filed by AGP FRANKLIN, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 12,954 sharesChange vs previous 13F not available
1.4% of the 13F portfolio, value $2,265,007.
13F-HR 0001951757-25-000522 filed by AGP FRANKLIN, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).